Filing Details
- Accession Number:
- 0001127602-24-003099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-02 16:07:51
- Reporting Period:
- 2024-02-02
- Accepted Time:
- 2024-02-02 16:07:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189403 | Steven Mizell | Merck &Amp; Co., Inc. 126 East Lincoln Avenue Rahway NJ 07065 | Evp, Chief Hr Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-02 | 824 | $70.71 | 42,143 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-02 | 32,170 | $73.73 | 74,313 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-02 | 50,694 | $126.65 | 23,619 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-02 | 824 | $0.00 | 824 | $70.71 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-02 | 32,170 | $0.00 | 32,170 | $73.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-10-30 | 2028-10-29 | No | 4 | M | Direct |
| 22,088 | 2022-05-04 | 2031-05-03 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
- The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
Billionaire Hedge Funds
